BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC)

CUSIP: 088786108

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class
Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
Total 13F shares
40,439,351
Total 13F value
$915,266,321
Holder snapshot 6 visible 7 signals
Share change
+699,612
Put/Call ratio
126%
SEC-reported price per share
$22.63
Number of holders
104
Value change
+$21,080,974
Number of buys
50
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
50,340,741

Security key

088786108

Report period

Q3 2024

Institutions

104

Top holders

10

BCYC full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 BICYCLE THERAPEUTICS PLC SEC filings BICYCLE THERAPEUTICS PLC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F Lead comparable stake: 19% Showing 1-6 of 15 holder rows.

Quick read

BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 19%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership Top 5
BAKER BROS. ADVISORS LP 19%
Deep Track Capital, LP 6.9%
RA CAPITAL MANAGEMENT, L.P. 4.5%
FCPM III SERVICES B.V. 4.2%
ARMISTICE CAPITAL, LLC 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
13F
Company
13F
19%
$190,255,190
9,399,960 shares
 — 30 Jun 2024
Deep Track Capital, LP
13F
Company
13F
6.9%
$70,647,841
3,490,506 shares
 — 30 Jun 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
4.5%
$45,600,720
2,253,000 shares
 — 30 Jun 2024
FCPM III SERVICES B.V.
13F
Company
13F
4.2%
$42,967,334
2,122,892 shares
 — 30 Jun 2024
ARMISTICE CAPITAL, LLC
13F
Company
13F
3.9%
$39,913,280
1,972,000 shares
 — 30 Jun 2024
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
13F
3%
$30,842,845
1,523,856 shares
 — 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
104
Shares
40,439,351
Rows available
104
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
105
Q3 2024 holders
104
Holder diff
-1
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .